Latest filing published 24 Feb 2015 for NPS PHARMACEUTICALS INC, €372k.
No signal scores available.
James G. Groninger discloses dealings in 2 companies, chiefly Cygne Designs Inc and NPS Pharmaceuticals Inc. We count 30 filings; the first trade dates from 10 January 2006 and the latest from 21 February 2015.
Sales make up the whole of the open-market record (7 sales, €590k). Other entries cover 5 share grants and 15 option exercises.
The record was last updated on 24 February 2015 with a transaction (€372k) in NPS Pharmaceuticals Inc. Typically, a trade is published a median of 6 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 29 declarations